# Callan JMB Inc.: overview CJMB · Nasdaq · CIK 2032545 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cjmb.md) · [Financials](/companies/cjmb/financials.md) · [Filings](/companies/cjmb/filings.md) · [Insiders](/companies/cjmb/insiders.md) Latest reported revenue: [$1.4m](/filings/0001493152-26-038329.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038329). ## Last eight quarters | Line item | Unit | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,435](/filings/0001493152-25-023475.md) | [1,352 d](/filings/0001493152-26-014292.md) | [1,449](/filings/0001493152-26-023708.md) | [1,666](/filings/0001493152-26-038329.md) | [1,447](/filings/0001493152-25-023475.md) | [1,161 d](/filings/0001493152-26-014292.md) | [1,106](/filings/0001493152-26-023708.md) | [1,376](/filings/0001493152-26-038329.md) | | Gross margin | % | [32.4%](/filings/0001493152-25-023475.md) | [31.0% d](/filings/0001493152-26-014292.md) | [42.5%](/filings/0001493152-26-023708.md) | [38.6%](/filings/0001493152-26-038329.md) | [34.1%](/filings/0001493152-25-023475.md) | [30.5% d](/filings/0001493152-26-014292.md) | [38.6%](/filings/0001493152-26-023708.md) | [55.1%](/filings/0001493152-26-038329.md) | | Operating margin | % | [(54.4%)](/filings/0001493152-25-023475.md) | [(94.2%) d](/filings/0001493152-26-014292.md) | [(85.4%)](/filings/0001493152-26-023708.md) | [(84.4%)](/filings/0001493152-26-038329.md) | [(129.9%)](/filings/0001493152-25-023475.md) | [(216.3%) d](/filings/0001493152-26-014292.md) | [(153.8%)](/filings/0001493152-26-023708.md) | [(97.8%)](/filings/0001493152-26-038329.md) | | Net margin | % | [(56.1%)](/filings/0001493152-25-023475.md) | [(95.8%) d](/filings/0001493152-26-014292.md) | [(85.6%)](/filings/0001493152-26-038329.md) | [(84.1%)](/filings/0001493152-26-038329.md) | [(188.8%)](/filings/0001493152-25-023475.md) | [(223.4%) d](/filings/0001493152-26-014292.md) | [(290.7%)](/filings/0001493152-26-038329.md) | [(89.5%)](/filings/0001493152-26-038329.md) | | Diluted EPS | $ per share | [(0.27)](/filings/0001493152-25-023475.md) | not reported | [(0.59)](/filings/0001493152-26-023708.md) | [(0.31)](/filings/0001493152-26-038329.md) | [(0.61)](/filings/0001493152-25-023475.md) | not reported | [(0.32)](/filings/0001493152-26-023708.md) | [(0.22)](/filings/0001493152-26-038329.md) | | Free cash flow | $k | [988 d](/filings/0001493152-25-023475.md) | [(723) d](/filings/0001493152-26-014292.md) | [(1,577)](/filings/0001493152-26-023708.md) | [(996) d](/filings/0001493152-26-038329.md) | [(1,932) d](/filings/0001493152-25-023475.md) | [(659) d](/filings/0001493152-26-014292.md) | [(1,715)](/filings/0001493152-26-023708.md) | [(430) d](/filings/0001493152-26-038329.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | | Revenue | $m | [13.2](/filings/0001641172-25-001249.md) | [6.6](/filings/0001493152-26-014292.md) | [5.7](/filings/0001493152-26-014292.md) | | Gross margin | % | [42.8%](/filings/0001641172-25-001249.md) | [39.1%](/filings/0001493152-26-014292.md) | [36.8%](/filings/0001493152-26-014292.md) | | Operating margin | % | [16.7%](/filings/0001641172-25-001249.md) | [(34.7%)](/filings/0001493152-26-014292.md) | [(122.9%)](/filings/0001493152-26-014292.md) | | Net margin | % | [16.5%](/filings/0001641172-25-001249.md) | [(34.9%)](/filings/0001493152-26-014292.md) | [(139.2%)](/filings/0001493152-26-014292.md) | | Diluted EPS | $ per share | not reported | [(0.87)](/filings/0001493152-26-014292.md) | [(1.82)](/filings/0001493152-26-014292.md) | | Free cash flow | $m | [6.5](/filings/0001641172-25-001249.md) | [0.5](/filings/0001493152-26-014292.md) | [(5.2)](/filings/0001493152-26-014292.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cjmb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Qsemble Capital Management, LP](/funds/1766159.md) | 2026-06-30 | $377.7k | 1,561 | | Reduced −3,267 | | [Creative Planning](/funds/1540235.md) | 2026-06-30 | $205.6k | 255,693 | | Unchanged | | [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $184.3k | 229,250 | | Reduced −16,232 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $25.8k | 32,086 | | New +32,086 | | [AXXCESS WEALTH MANAGEMENT, LLC](/funds/1911056.md) | 2026-06-30 | $20.1k | 25,000 | | New +25,000 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $12.6k | 15,672 | | Reduced −7,297 | | [Financial Plan, Inc.](/funds/2107584.md) | 2026-06-30 | $10.9k | 13,500 | | New +13,500 | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $10.8k | 13,423 | | New +13,423 | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $10.1k | 12,500 | | Unchanged | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $9.1k | 11,287 | | New +11,287 | ## Recent filings [All 97 filings](/companies/cjmb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 12:10 ET | [8-K](/filings/0001493152-26-047507.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-047507 | | 2026-10-16 | 20:10 ET | [8-K](/filings/0001493152-26-047399.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-047399 | | 2026-09-01 | 20:15 ET | [8-K](/filings/0001493152-26-041017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041017 | | 2026-08-31 | 20:30 ET | [8-K](/filings/0001493152-26-040838.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-040838 | | 2026-08-24 | 10:15 ET | [8-K](/filings/0001493152-26-039761.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-039761 | | 2026-08-20 | 10:02 ET | [8-K](/filings/0001493152-26-039329.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-039329 | | 2026-08-14 | 20:06 ET | [10-Q](/filings/0001493152-26-038329.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038329 | | 2026-07-02 | 21:15 ET | [8-K](/filings/0001493152-26-031963.md) | 3.01 Delisting notice | 0001493152-26-031963 | | 2026-06-11 | 20:01 ET | [8-K](/filings/0001493152-26-028275.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-028275 | | 2026-05-27 | 21:40 ET | [8-K](/filings/0001493152-26-025298.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-025298 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014292.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/12e57cc4-1556-409a-96e2-12b6afb109c8) ## About the filer - CIK: 2032545 - Tickers: CJMB - Exchange: Nasdaq - SIC code: 7389 Services-Business Services, NEC - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.